Login to South West London Pathology Services

If you have any queries about pathology consumables – you need a new account or you have a query about your order, please telephone 020 8266 6827. Forgotten your password

The 100k Genome Project

SWLP’s Cellular Pathology dept are part of the ground-breaking 100k Genome Project. The Genome Project aims to establish the UK as a world leader in genetic research and to transform patient care using genetic information.

The national 100k Genomes Project will focus on rare genetic diseases (80%) and cancer (20%) and will enable pioneering research to decode 100,000 human genomes, a scale not seen anywhere else in the world.

The project has the potential to transform the future of healthcare. It could improve the prediction and prevention of disease, enable new and more precise diagnostic tests, and allow personalisation of drugs and other treatments.

Genomic Medical Centres
Across England there are 13 Genomic Medical Centres and SWLP is part of the South London NHS Genomic Medicine Centre, working with Kings College, and Guy’s and St Thomas’ Hospitals.

The cellular pathology departments at all the hospital trusts are working with genetics and clinical teams in relation to recruiting suitable patients with tumours to the programme, for collecting blood and tumour samples and for extracting DNA from relevant samples.

The St George’s clinical lead for the 100k genome cancer project is Dr Ruth Pettengell, based at St George’s University. The lead pathologist for SWLP is Dr Colan Ho-Yen with Samantha Matthews as technical lead in cellular pathology.

Current progress:

Nationally – medical centres have been working on protocols for tissue processing and, working in parallel, a developmental group has identified fresh frozen tissue as the way ahead.

Locally – IT leads in SWLP and the Genetics dept at St George’s have been working with colleagues at Guy’s Hospital to ensure accurate data upload onto the national database. The internal process for tissue handling have also been agreed and approved by Genomics England. Having had several dry runs to ensure the process works, the good news is that we are now ready for our first patient recruit.

For more information watch the Youtube videos below about the 100k Genome project and genomics in healthcare

http://www.youtube.com/watch?feature=player_embedded&v=gW6CUCYw7Vs

Latest news

July 8, 2026

New test codes for requesting immunoglobulins – Epsom and St Helier hospitals and GPs only

Immunoglobulin and serum protein electrophoresis requesting is changing on 8 July 2026. Clinicians can now request immunoglobulins only or immunoglobulins and electrophoresis. This change will enable doctors to more effectively request the tests that are clinically indicated and streamline laboratory testing, delivering improved turnaround times for these tests. This change will apply to Epsom & St Helier Hospitals and their associated GPs initially, and will then be rolled out to all service users in south west London.

Read more
June 12, 2026

Kim Brown: gesh celebrating an NHS leader and mentor 27 years in the making!

After 27 years of dedicated service to the NHS, Kim Brown, Technical Lead in Biochemistry, has finally received the recognition she richly deserves through the gesh Long Service Awards.

Read more
June 8, 2026

From Milton Keynes to Network Lead: Sewa Joacquim-Hearne on collaboration, chaos, and a career in blood transfusion

Just three weeks into her new role as Blood Transfusion (BT) Network Lead for SWLP, Sewa Joacquim-Hearne is already on the move. Based at St George’s Hospital but with a presence planned across all five sites, including Epsom, St Helier, Kingston, and Croydon, she is taking on a role that is as much about connection as it is about clinical expertise.

Read more
May 26, 2026

SWLP Microbiologist presents groundbreaking TB research at ESCMID Global 2026

Shanthiya Akeesan, a Specialist Biomedical Scientist at Epsom and St Helier delivered a highly successful booth presentation on latent tuberculosis infection (LTBI) screening at ESCMID Global 2026 in Munich, Germany. The presentation, titled ‘Evaluation of a fully automated second-generation interferon-gamma release assay for latent tuberculosis infection: diagnostic performance and clinical implications’, showcased Shanthiya’s research into […]

Read more